Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

  1. Stolz, D.
  2. Hermansson, E.
  3. Ouwens, M.
  4. Singh, B.
  5. Sharma, A.
  6. Jackson, D.
  7. Darken, P.
  8. Marshall, J.
  9. Bowen, K.
  10. Müllerová, H.
  11. Alcázar Navarrete, B.
  12. Russell, R.
  13. Han, M.K.
  14. Tansey-Dwyer, D.
Revue:
Current Medical Research and Opinion

ISSN: 1473-4877,  0300-7995

Année de publication: 2023

Volumen: 39

Número: 10

Pages: 1395-1405

Type: Article

DOI: 10.1080/03007995.2023.2247969 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus